Insider Trading History of Mckenney Charles


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mckenney Charles since year 2005. The trader's CIK number is 1296735. At the time of the last reporting, Mckenney Charles was the Director of Arrowhead Pharmaceuticals, Inc. . (stock ticker symbol ARWR). See this page for all insider trading activities at Arrowhead Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Mckenney Charles since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-10-01 ARWR Arrowhead Pharmaceuticals, Inc. Sale 2,500 14.70 36,747
2014-10-01 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 2,500 5.19 12,975
2014-06-09 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 22,000 2.40 52,909
2014-06-09 ARWR Arrowhead Pharmaceuticals, Inc. Sale 22,000 14.32 314,996
2007-12-05 ARWR Arrowhead Pharmaceuticals, Inc. Sale 1,000 3.86 3,860
2007-11-05 ARWR Arrowhead Pharmaceuticals, Inc. Sale 1,000 3.91 3,910
2007-10-05 ARWR Arrowhead Pharmaceuticals, Inc. Sale 1,000 5.00 5,000
2007-09-05 ARWR Arrowhead Pharmaceuticals, Inc. Sale 1,000 5.04 5,040
2007-08-06 ARWR Arrowhead Pharmaceuticals, Inc. Sale 1,000 5.44 5,440
2007-07-05 ARWR Arrowhead Pharmaceuticals, Inc. Sale 1,000 4.88 4,880
2007-06-05 ARWR Arrowhead Pharmaceuticals, Inc. Sale 1,000 7.21 7,210
2007-05-07 ARWR Arrowhead Pharmaceuticals, Inc. Sale 1,000 7.00 7,000
2007-04-05 ARWR Arrowhead Pharmaceuticals, Inc. Sale 1,000 4.58 4,576
2007-03-05 ARWR Arrowhead Pharmaceuticals, Inc. Sale 1,000 3.75 3,750
2007-02-20 ARWR Arrowhead Pharmaceuticals, Inc. Sale 500 3.98 1,990
2007-02-05 ARWR Arrowhead Pharmaceuticals, Inc. Sale 500 4.04 2,020
2007-01-22 ARWR Arrowhead Pharmaceuticals, Inc. Sale 500 4.01 2,005
2007-01-16 ARWR Arrowhead Pharmaceuticals, Inc. Sale 500 4.01 2,005

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mckenney Charles (Director of Arrowhead Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month